• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CO2, gadolinium prove utility in uterine fibroids treatment

Article

Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.

Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.

Dr. Hyun S. Kim, an assistant professor of radiology at Hopkins, and colleagues evaluated the technique in eight patients with symptomatic fibroids. The patients underwent angiography after injection of about 30 to 40 mL of CO2 using a commercially available microcatheter system. They then received the embolization agent mixed with a low dose of the gadolinium-based contrast agent. This approach worked safely and effectively as contrast media in this group of patients, without major complications (J Vasc Interv Radiol 2007;18 [8]:1021-1027).

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.